Tokyo Tape
Sign in
← OLBA Healthcare Holdings

Quarterly report · Q3

2689.TEDINET S100QQLZ
Period2022-07-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥82.9bn2022-07-01 → 2023-03-31Cons.Net sales
Revenue¥108.0bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥81.8bn2021-07-01 → 2022-03-31Cons.Net sales
Operating income¥1.6bn2022-07-01 → 2023-03-31Cons.Operating income
Operating income¥1.7bn2021-07-01 → 2022-03-31Cons.Operating income
Ordinary income¥1.6bn2022-07-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥2.1bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2021-07-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥1.6bn2022-07-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥1.7bn2021-07-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥1.0bn2022-07-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2021-07-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.0bn2022-07-01 → 2023-03-31Cons.Profit loss
Net income¥1.1bn2021-07-01 → 2022-03-31Cons.Profit loss
Total assets¥41.9bnat 2023-03-31Cons.Assets
Total assets¥40.0bnat 2022-06-30Cons.Assets
Total assets¥42.4bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥32.1bnat 2023-03-31Cons.Liabilities
Total liabilities¥30.9bnat 2022-06-30Cons.Liabilities
Net assets / equity¥9.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥9.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥8.9bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥3.2bnat 2022-06-30Cons.Cash and deposits
EPS (basic)¥171.792022-07-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.662023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.82021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥186.292021-07-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥98.712022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio23.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.8%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio21.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2023-03-31−¥1.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2023-03-31−¥1.2bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2023-03-31−¥94m
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue external2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥554,000
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentsegment profit2022-07-01 → 2023-03-31¥142m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue2022-07-01 → 2023-03-31¥78.3bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue external2022-07-01 → 2023-03-31¥77.2bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥1.1bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentsegment profit2022-07-01 → 2023-03-31¥1.4bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue2022-07-01 → 2023-03-31¥3.9bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue external2022-07-01 → 2023-03-31¥3.8bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥95m
jpcrp040300-q3r_E02928-000SPDreportable segmentsegment profit2022-07-01 → 2023-03-31¥148m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2023-03-31¥84.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2023-03-31¥82.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2023-03-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2023-03-31¥1.7bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2022-03-31−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2022-03-31−¥1.0bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2022-03-31−¥103m
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue2021-07-01 → 2022-03-31¥1.8bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue external2021-07-01 → 2022-03-31¥1.8bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2021-07-01 → 2022-03-31¥537,000
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentsegment profit2021-07-01 → 2022-03-31¥132m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue2021-07-01 → 2022-03-31¥77.5bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue external2021-07-01 → 2022-03-31¥76.6bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2021-07-01 → 2022-03-31¥909m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentsegment profit2021-07-01 → 2022-03-31¥1.5bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue2021-07-01 → 2022-03-31¥3.5bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue external2021-07-01 → 2022-03-31¥3.4bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue intersegment2021-07-01 → 2022-03-31¥94m
jpcrp040300-q3r_E02928-000SPDreportable segmentsegment profit2021-07-01 → 2022-03-31¥118m
Total Of Reportable Segments And Otherssegment totalrevenue2021-07-01 → 2022-03-31¥82.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-07-01 → 2022-03-31¥81.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-07-01 → 2022-03-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-07-01 → 2022-03-31¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 356
ItemContextValueUnit
Provision for share based remuneration for directors and other officers nclPrior1YearInstant212628000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant221307000JPY
Net defined benefit liabilityPrior1YearInstant435912000JPY
Net defined benefit liabilityCurrentQuarterInstant434764000JPY
Long term accounts payable otherPrior1YearInstant278127000JPY
Long term accounts payable otherCurrentQuarterInstant175077000JPY
Other nclPrior1YearInstant1027590000JPY
Other nclCurrentQuarterInstant1132318000JPY
Noncurrent liabilitiesPrior1YearInstant2009258000JPY
Noncurrent liabilitiesCurrentQuarterInstant1963467000JPY
LiabilitiesPrior1YearInstant30875365000JPY
LiabilitiesCurrentQuarterInstant32099902000JPY
Capital stockPrior1YearInstant607750000JPY
Capital stockCurrentQuarterInstant607750000JPY
Capital surplusPrior1YearInstant315704000JPY
Capital surplusCurrentQuarterInstant321534000JPY
Retained earningsPrior1YearInstant8369369000JPY
Retained earningsCurrentQuarterInstant9035917000JPY
Treasury stockPrior1YearInstant-375903000JPY
Treasury stockCurrentQuarterInstant-342042000JPY
Shareholders equityPrior1YearInstant8916919000JPY
Shareholders equityCurrentQuarterInstant9623158000JPY
Valuation difference on available for sale securitiesPrior1YearInstant121157000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant104175000JPY
Remeasurements of defined benefit plansPrior1YearInstant55229000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant48160000JPY
Valuation and translation adjustmentsPrior1YearInstant176387000JPY
Valuation and translation adjustmentsCurrentQuarterInstant152335000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant9093306000JPY
Net assetsCurrentQuarterInstant9775494000JPY
Liabilities and net assetsPrior1YearInstant39968672000JPY
Liabilities and net assetsCurrentQuarterInstant41875396000JPY
Net salesPrior1YTDDuration81756761000JPY
Net salesCurrentYTDDuration82852973000JPY
Cost of salesPrior1YTDDuration72425239000JPY
Cost of salesCurrentYTDDuration73265787000JPY
Gross profitPrior1YTDDuration9331522000JPY
Gross profitCurrentYTDDuration9587186000JPY
Selling general and administrative expensesPrior1YTDDuration7653139000JPY
Selling general and administrative expensesCurrentYTDDuration8014111000JPY
Operating incomePrior1YTDDuration1678383000JPY
Operating incomeCurrentYTDDuration1573074000JPY
Interest income noiPrior1YTDDuration185000JPY
Interest income noiCurrentYTDDuration203000JPY
Dividends income noiPrior1YTDDuration768000JPY
Dividends income noiCurrentYTDDuration912000JPY
Insurance income noiPrior1YTDDuration7626000JPY
Insurance income noiCurrentYTDDuration376000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-06-30pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-07-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-07-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass